Skip to main content
Home

Oncologieportal

Main navigation

  • Oncologieportal
    • Borst
    • Endocrinologie
    • Gastro-Enterologie
    • Gynaecologie
    • Hematologie
    • Hoofd-Halsgebied
    • Huid
    • Long/Mesotheliomen
    • Neurologie
    • Pediatrie
    • Sarcoom
    • Urologie en Nefrologie
  • Medi-Access
background_placeholder
Medscape: Hematology/Oncology Headlines

Articles about Medscape: Hematology/Oncology Headlines

     
Kies meer
In Trending

FDA Okays Liso-cel for Second Line in Large B-cell Lymphoma

In Trending

No Survival Gain From High-Dose Cytarabine Consolidation in AML

In Trending

Zanubrutinib-Obinutuzumab Doubles PFS in Follicular Lymphoma

In Trending

New CAR-T Therapy Elicits Strong Response in Multiple Myeloma

In Trending

Venetoclax Combos Improve Progression-Free Survival in CLL

In Trending

Momelotinib Hits the Mark for Deadly Bone Marrow Cancer

In Trending

Quizartinib Doubles Overall Survival in FLT3-ITD-Positive AML

In Trending

Similar Survival, Less Toxicity With Decitabine vs Chemo in AML

Trending

Er zijn @count nieuwe artikelen
Monday, June 27, 2022 - 18:32Nieuw
FDA Okays Liso-cel for Second Line in Large B-cell Lymphoma
Thursday, June 23, 2022 - 16:40 - In Trending
No Survival Gain From High-Dose Cytarabine Consolidation in AML
Friday, June 17, 2022 - 20:32 - In Trending
Zanubrutinib-Obinutuzumab Doubles PFS in Follicular Lymphoma
Thursday, June 16, 2022 - 21:24 - In Trending
New CAR-T Therapy Elicits Strong Response in Multiple Myeloma
Wednesday, June 15, 2022 - 18:32 - In Trending
Venetoclax Combos Improve Progression-Free Survival in CLL
Wednesday, June 15, 2022 - 18:32 - In Trending
Momelotinib Hits the Mark for Deadly Bone Marrow Cancer
Monday, June 13, 2022 - 17:40 - In Trending
Quizartinib Doubles Overall Survival in FLT3-ITD-Positive AML
Sunday, June 12, 2022 - 20:32 - In Trending
Similar Survival, Less Toxicity With Decitabine vs Chemo in AML
Saturday, June 11, 2022 - 01:08 - In Trending
A New First-line Regimen for Advanced Hodgkin Lymphoma?
Monday, June 6, 2022 - 16:16 - In Trending
Teclistamab Shows 'Promising' Activity in R/R Multiple Myeloma

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • ›› Next page
  • » Last page

Kies uw tags

lymphoma
multiple myeloma
diffuse large b-cell lymphoma
leukemia
myelodysplastic syndrome
leukaemia
non-hodgkin
acute myeloid leukemia
AML
hematological malignancies
hodgkin
hodgkin lymphoma
CLL
follicular lymphoma
chronic myeloid leukemia
myelofibrosis
mantle cell lymphoma
hematological malignancy

Medzine logo gekleurd

Word op de hoogte gehouden van de laatste ontwikkelingen binnen oncologie via MedZine. Het nieuws wordt samengesteld uit meer dan 4.700 wetenschappelijke journals, beroepsverenigingen en andere gezaghebbende websites.

Sitemap

  • Trending
  • Wetenschappelijk
  • Uw nieuws

Support

  • Contact
  • Privacyverklaring
  • Gebruik van cookies

Medix

FTO

CEFI

 CME Academy

FarmacoTherapie Online

Medi-Access